|
|
 |
 |
Search Results for: A |
 |
|
|
|
|
|
|
|
| 91 |
Andrographolide
Manus Aktteva offers Andrographolide, 5508-58-7,for your evaluation,pilots and commercial requirements
View Detail
|
 |
|
|
| 92 |
Aescin
Manus Aktteva offers Aescin, Escin, Chestnuts extract, 6805-41-0, 229-880-6, for your evaluation,pilots and commercial requirements
View Detail
|
|
|
|
| 93 |
Andrographis paniculata extract
Manus Aktteva offers Andrographis paniculata extract,for your evaluation,pilots and commercial requirements
View Detail
|
|
|
|
| 94 |
Artemether
Manus Aktteva offers Artemether, Ph, 71963-77-4,for your evaluation,pilots and commercial requirements
View Detail
|
|
|
|
| 95 |
Artesunate
Manus Aktteva offers Artesunate, Ph,88495-63-0,for your evaluation,pilots and commercial requirements
View Detail
|
|
|
|
|
|
|
|
|
 |
NOTE: 
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|